Table 3 Specificities at given sensitivities for selected individual biomarkers and biomarker combinations.

From: Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease

Biomarker/Biomarker Combination

AUC

Specificity at a Sensitivity of

95%

90%

85%

80%

S100A8/A9

0.827

19.1%

48.9%

74.5%

76.6%

CRP

0.837

34.0%

59.6%

70.2%

76.6%

S100A8/A9 + CRP

0.830

46.8%

46.8%

74.5%

76.6%

S100A8/A9 + TSP1

0.872

70.2%

78.7%

78.7%

80.9%

S100A8/A9 + TSP1 + IFNL1

0.913

80.9%

80.9%

83.0%

83.0%

S100A8/A9 + TSP1 + ERBB2

0.898

74.5%

78.7%

85.1%

85.1%

S100A8/A9 + TSP1 + FINC + IFNL1

0.928

63.8%

83.0%

87.2%

87.2%